SlideShare a Scribd company logo
1
Rewards of Smoking
Cessation
Highlights on
By
In the past century smoking was common
as a symbol of simple pleasures
In the past century smoking was common
as a symbol of simple pleasures
Pipe would stand for thoughtfulness
and calm
Cigarette symbolized modernity,
strength and youth, but also nervous
anxiety
Cigar was a sign of authority, wealth
and power
Times have changed
Smoking is less socially acceptable now than ever...
Uncovering the effects of smoking
historical perspective
In retrospect it can now be seen that medical evidence of the
harm done by smoking has been accumulating for many years
The evidence was generally ignored until five case-control
studies relating smoking to the development of lung cancer were
published in 1950.
The interpretation that smoking caused various diseases was
vigorously debated for some years but came to be generally
accepted in respect of lung cancer by the late 1950s and of
many other diseases in the subsequent two decades.
Nothing Kills Like Tobacco
Tobacco : Deadly in any form
26
WHO World Health Report .Tobacco Atlas .2008.
Global Cigarette Consumption
33
36
Where is the burden increasing the fastest,
1990 to 2020?
India
+1400%Middle
Eastern
Crescent
+700%
India
+1400%Middle
Eastern
Crescent
+700%
Latin
American
and
Caribbean
+300%
India
+1400%
India
+1400%Middle
Eastern
Crescent
+700%
Latin
American
and
Caribbean
+300%
Other Asia
and Islands
+250%
India
+1400%Middle
Eastern
Crescent
+700%
Latin
American
and
Caribbean
+300%
Sub-
Saharan
Africa
+200%
Other Asia
and Islands
+250%
India
+1400%Middle
Eastern
Crescent
+700%
Latin
American
and
Caribbean
+300%
Sub-
Saharan
Africa
+200%
Other Asia
and Islands
+250%
China
+175%
India
+1400%Middle
Eastern
Crescent
+700%
Latin
American
and
Caribbean
+300%
Sub-
Saharan
Africa
+200%
Other Asia
and Islands
+250%
China
+175%
Formerly Socialist
Economies of Europe
+120%
India
+1400%Middle
Eastern
Crescent
+700%
Latin
American
and
Caribbean
+300%
Sub-
Saharan
Africa
+200%
Other Asia
and Islands
+250%
China
+175%
Formerly Socialist
Economies of Europe
+120%
Established Market
Economies
+18%
The Economics of Tobacco andTobacco Taxation in Egypt 2010
International Union Against Tuberculosis and Lung Disease
Tobacco Road Map
Top 10 male smoking populations 2008
Decrease in smoking prevalence
• In 1950, about 80%
of UK men smoked
United Kingdom, 1950-2002
1950 1960 1970 1980 1990 2000
0
20
40
60
80
%
at ages
35-59
70%
50%
28%
26%
% smoked
% smoked
• In 1970, UK male death
rates from smoking were
the worst in the world
• 1970-2000, decrease in
male death rates from
smoking was the
best in the world
The Decline in US Smoking Prevalence
47
Growing Recognition of Value
of Smoking Cessation
 Smoking cessation intervention is one of the most cost-
effective interventions in medicine
 Compared with other preventive interventions, smoking
cessation is extremely cost-effective.
 Smoking cessation has been called the 'gold standard'
of health care cost effectiveness, producing additional
years of life at costs that are well below those estimated
for a wide range of healthcare interventions.
 Tobacco-use screening and intervention for adults
 Aspirin chemoprophylaxis for adults
 Childhood immunization
 Colorectal cancer screening
 Hypertension screening
 Influenza immunization
 Pneumococcal immunization
 Problem-drinking screening and brief counseling
 Vision screening—adults
 Cervical cancer screening
 Cholesterol screening
Smoking Cessation intervention
One of the Top 3 Most Important Areas for Focus
• The NCPP highlighted priorities among effective clinical preventive services
• Total score for each service is based on 2 measures: clinically preventable
burden and cost-effectiveness (both scored from 1 to 5 points)
Highest Ranking
Total Score: 10
Total Score: 8
Total Score: 7
Despite having a high ranking, tobacco-use screening and intervention still have low utilization rates.
NCPP=National Commission on Prevention Priorities.
Maciosek MV et al. Am J Prev Med. 2006;31(1):52-61. 50
Leading Health Agencies and Organizations Have
Recognized the Value and Are Advocating for Change
– Centers for Disease Control and Prevention (CDC)
– US Preventive Services Task Force (USPSTF)
– National Business Group on Health (NBGH)
– National Commission on Prevention Priorities (NCPP)
– World Health Organization (WHO)
52
Tobacco use is a risk factor for six of the eight
leading causes of death in the world
Smoking and
Life span
Finally, here’s a nice example of what stopping smoking can offer.
Richard Doll (1912-2005), who stopped smoking cigarettes at age 37,
photographed aged 91 at the 2004 BMJ press conference
on the 50-year results from his study of British doctorsMichael Crabtree, copyright Troika
Photos
Study of smoking and death
in male British doctors
• Recorded all deaths for 50 years (1951-2001)
• Main findings (for men born in the 20th century)
– Smokers lose, on average, 10 years of healthy life
• Asked all UK doctors in 1951, and periodically
thereafter, what they themselves smoked
– Stopping smoking at any age will add years to a persons life
– Those who stop smoking before 35 years of age avoid almost
all of the excess risk will have a life expectancy no different
from that of a nonsmoker.
Age40
A Study of Male Physicians Showed Quitting at Any Age
Increases Life Expectancy
35-44 years
Patients were studied over the period of 1951-2001.
Adapted from Doll R et al. BMJ. 2004;328:1519-1527.
Years
Nonsmokers
Cigarette Smokers
Stopped Age
%SurvivalFromMean
Quitatage35-44
Additional
9-year
life expectancy
60
N=34,439 British male physicians.
A Study of Male Physicians Showed Quitting at Any Age
Increases Life Expectancy
Patients were studied over the period of 1951-2001.
Adapted from Doll R et al. BMJ. 2004;328:1519-1527.
Years
%SurvivalFromMean
Age50
Quitatage45-54
Additional
6-year
life expectancy
45-54 years
61
Nonsmokers
Cigarette Smokers
Stopped Age
N=34,439 British male physicians.
A Study of Male Physicians Showed Quitting at Any Age
Increases Life Expectancy
Patients were studied over the period of 1951-2001.
Adapted from Doll R et al. BMJ. 2004;328:1519-1527.
Years
%SurvivalFromMean
Age60
Quitatage55-64
Additional
3-year
life expectancy
55-64 years
62
Nonsmokers
Cigarette Smokers
Stopped Age
N=34,439 British male physicians.
Tobacco is the single largest preventable cause
of cancer in the world today
74
Stopping smoking: avoiding lung cancer
% dead from
lung cancer
Continued smoking:
16% dead from lung cancer
Stopped age 50: 6%
Stopped age 30: 2%
Never smoked: <1%
15
10
5
0
45 55 65 75
Age
Cumulative risk at
UK male 1990 rates
BMJ 2000; 321: 323-9
80
81
82
83
• People diagnosed with cancer should quit smoking.
For those having surgery, chemotherapy, quitting
smoking helps improve the body’s ability to heal
and respond to therapy .
• It also lowers the risk of pneumonia and respiratory
failure .
• For people who have already developed cancer, quitting
smoking reduces the risk of the cancer returning or
developing a second cancer .
87
89
 One out of every five smoking-related deaths are
caused by cardiovascular diseases.
 Cigarette smokers are two to four times more likely to
develop coronary heart disease than non-smokers.
 Cigarette smoking doubles a person's risk of stroke.
 Cigarette smokers are more than ten times as likely as
non-smokers to develop peripheral vascular disease
 Smoking causes abdominal aortic aneurysm
The American Heart Association
 The risk for CAD among smokers is dose related &
smoking as little as one to four cigarettes per day
significantly increases risk.
 Smoking cessation should be viewed as therapeutic
rather than preventive intervention.
93
94
Smoking and Cardiovascular Diseases
96
97
98
 Smokers also have a higher risk of recurrent ischemia
after coronary artery bypass graft surgery and of re-
occlusion after an acute myocardial infarction
 For those smokers with diagnosed CHD, stopping
smoking appears to reduce the risk of recurrent
infarction and cardiovascular death by 50% or more.
 Smoking cessation is crucial in the management of
many contributors to heart attack e.g atherosclerosis.
 Smoking cessation significantly lowers the risk of
atherosclerosis
110
The American Heart Association
Increases LDL
Decreases HDL
Slightly increases triglycerides
Smoking and hypercholestorlemia
114
115
116
The American Heart Association
Smoking increases the cardiovascular risk, at any level
of blood pressure, for coronary heart disease, stroke
Drug treatment of hypertension is less effective in
smokers
Smoking should be avoided in any hypertensive patient
Smoking and hypertension
Diabetes and High Blood Pressure are Like Twins
119
120
The American Heart Association
Smoking has a multiplicative interaction with the major
risk factors for coronary artery disease, to increase
disease risk.
For example, if the presence of smoking alone doubles
the level of risk for CAD, the presence of another major
risk factor in conjunction with smoking results in
approximately a 4-fold increase in risk .
The presence of 2 other risk factors together with
smoking results in approximately an 8-fold increase in
risk.
Multiplicative Risk Factor CAD
123
125
126
127
130
131
132
133
134
Relationship Between CKD and CVD
CKD = chronic kidney disease; CVD = cardiovascular disease; CV = cardiovascular.
1. Menon V et al. Am J Kidney Dis. 2005;45:223–232.
CVD
CKD
Traditional
CV risk factors
Non-traditional
CV risk factors
CKD is a risk factor for CVD, and CVD may be a risk factor for the progression of CKD
Diabetes or hypertension are the two leading causes of
chronic kidney disease.
Smokers with diabetes or hypertension face an accelerated
rate of kidney damage compared to non-smokers with
chronic kidney disease, resulting in a much quicker
progress towards ESRD .
137
138
Diabetes Amplifies the CKD and CVD Paradigm
139
Smoking Is the Single Most Important Risk Factor for
COPD
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, Global Initiative for Chronic
Obstructive Lung Disease (GOLD) 2008. Available from: http://www.goldcopd.org.
146
147
1990 2020
Ischaemic heart disease
Cerebrovascular disease
Lower resp infection
Diarrhoeal disease
Perinatal disorders
COPD
Tuberculosis
Measles
Road Traffic Accidents
Lung Cancer
Stomach Cancer
HIV
Suicide
6th
3rd
Future Mortality Worldwide
Source: Murray & Lopez. Lancet 1997
Am. J. Respir. Crit. Care Med. 2002; 166: 675-679
Years
FEV1(L)
2.0
2.1
2.2
2.3
2.4
2.5
2.6
2.7
2.8
2.9
0 1 2 3 4 5 6 7 8 9 10 11
Continuous smokers
Disease Progression in COPD
Lung Function
potential effect of stopping smoking early or late in the course of
COPD.
Fletcher CM, Peto R. BMJ. 1977;1:1645-1648. Reproduced with permissions from BMJ Publishing Group.
Smoked
regularly and
susceptible to
effects of smoke
Never smoked
or not
susceptible to
smoke
Stopped
smoking at
45 (mild
COPD)
Stopped
smoking at
65 (severe
COPD)
Disability
Death
FEV1
(%ofvalueatage25)
25
50
75
100
0
Age (years)
25 50 75
Smoking and pulmonary function
Anthonisen et al. Smoking and lung function of Lung Health Study participants
after 11 years. Am J Respir Crit Care Med 2002.
• Smoking Cessation is Single most effective
and cost effective intervention to reduce
the risk of developing COPD and stop
its progression
Am J Respir Crit Care Med 2001
CRJ . 10;(Suppl A). 2003
Corticosteroid resistance
Laboratory Investigation advance online publication
24 July 2006; doi:10.1038/labinvest.3700456
154
Smoking doesn't cause asthma, but in people
having asthma smoking makes their asthma worse.
155
Cigarette smoking in asthma is a risk factor for poor
asthma control
Emergency department visits as a result of exacerbations
of asthma occur more frequently amongst heavy cigarette
smokers with asthma
Every effort should be made to encourage individuals with
asthma who smoke to quit.
ERS 2004
Cigarette smoking increases the clearance of theophylline
by 60–100% in smokers compared with nonsmokers
by induction of several metabolising enzymes
Cytochrome P450-1A2
Smoking cessation for 1 week reduces the elimination
of theophylline by 35%.
ERS 2004
158
159
160
161
Smoking and TB Form a Deadly Combination
 Cigarette smokers may be up to three times more likely
to develop latent TB infection than non-smokers
 For a person with latent TB infection, cigarette smoking
increases their risk of developing active TB disease by
two to three times, compared to non-smokers
 Smoking influences the clinical progress of TB lesions.
Smokers tend to have more cavitary disease, and were
more likely to be smear-positive compared to non-
smokers
 Smoking reduces the effectiveness of TB treatment which
can lead to longer periods of infection
 Smoking is associated with recurrent tuberculosis
disease and increase the risk of relapse
 Up to one in every five deaths from tuberculosis could be
avoided if the patients were not smokers
167
Smoking & liver
171
172
174
176
Patients submitted to liver transplantation are particularly
susceptible to increased postoperative pulmonary
complications esp. pneumonia
Transplanted patients who smoke have an increased risk
for vascular complications including hepatic artery
thrombosis
Herrero JI. Liver Transpl. 2011
Smoking cessation at least 2 years before liver
transplantation can significantly reduce the risk for
vascular complications.
Smoking cessation should be an essential requirement
for liver transplantation candidates to decrease the
morbidity arising from vascular complications
after liver transplantation.
Recurrence of viral hepatitis may be more frequent
among liver transplant recipients who are active or
former smokers
"Encouraging preoperative smoking cessation may
be beneficial in improving patient outcomes following
transplantation."
Other investigators recently reported that smoking
was a risk factor in the increased frequency of
malignancies after liver transplantation.
Smoking cessation after liver transplantation
reduced incidence of transplant-related carcinoma
186
187
Significant association between smoking and male sexual
impotence with the association increasing with the
number of cigarettes smoked per day
There is no “safe” level of smoking , even light smoking is
associated with reduced male fertility
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE 2003
ASH Factsheet: Smoking and reproduction 2008
Research has shown that men who smoke are 60% more
likely to experience erection problems such as impotence,
which is why smoking is considered to one of the prime
lifestyle causes of impotence.
Not only is smoking a singular cause of impotence, but it
can also amplify the effects of some of the other causes
of impotence such as diabetes, high blood pressure
193
Women who smoke have increased risks for conception
delay and for both primary and secondary infertility
Smoking cessation by women during their reproductive
years reduces the risk for infertility.
Smoking causes women to reach menopause one to two
years early, but former smokers have an age at natural
menopause similar to those who have never smoked
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE 2003
ASH Factsheet: Smoking and reproduction 2008
Smoking is strongly associated with an increased risk of
spontaneous miscarriage and possibly ectopic pregnancy.
Women who smoke during pregnancy are about twice as
likely to experience premature rupture of membranes,
placental abruption, and placenta previa during pregnancy
Pregnant women who smoke cigarettes run an increased
risk of having stillborn or premature infants or infants
with low birth weight.
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE 2003
ASH Factsheet: Smoking and reproduction 2008
Women who stop smoking before pregnancy or during the
first 3 to 4 months of pregnancy reduce their risk of having
a low birthweight baby to that of women who never smoked
Reducing the number of cigarettes smoked, rather than
quitting completely, does not appear to benefit birthweight
of the foetus.
Smoking cigarettes may contribute to inadequate breast
milk production
In breastfeeding mothers who smoke, milk output is
reduced by more than 250 ml per day compared with non-
smoking mothers.
Nicotine is rapidly transported from the smoking mother’s
blood to her breast milk. The infant may be less willing to
feed since the breast milk tastes bad.
ASH Factsheet: Smoking and reproduction February 2011
Smoking should be discouraged for both male and female
partners in couples with a history of infertility or recurrent
miscarriage.
Smoking cessation may improve natural fertility and
success rates with infertility treatment.
Smoking cessation for at least two months
before attempting in vitro fertilization (IVF)
significantly improved chances for conception.
201
207
208
209
210
211
Smoking has an inhibiting effect on estrogen ,the most
important hormone in preventing the loss of bone tissue.
Smoking is one of the risk factors for osteoporosis which
is a major cause of hip fracture.
Postmenopausal women who smoke have lower bone
density and an increased risk for hip fracture than women
who never smoked.
Stopping smoking prevents further excess bone loss.
213
214
216
218
219
220
221
222
223
224
Smoking can prematurely age the skin , Smokers’ skin can
be prematurely aged by between 10 and 20 years
The risk of moderate or severe facial wrinkling is 3 times
as high for women who smoke than those who have
never smoked and twice as high for male smokers
“Tobacco kills beauty and much more.”
234
Teenagers care about the immediate benefits to their
appearance, well being and financial status rather
more than future health gains
243
244
245
248
249
251
253
You’ll Save Money
Smoking is expensive - multiply how much money
you spend on tobacco every day by 365 (days per
year).
Your Self Esteem Will Improve
 You will feel more in
control of your life.
 Your self esteem will
improve by knowing
you are doing
something positive to
help yourself!
You’ll Look Better
 Your clothes and breath
will no longer smell like
smoke.
 Your teeth will be whiter.
 You’ll lose the yellow
nicotine stains on your
fingers
Food Will Taste Better
 Your sense of smell and
taste will return!
 Your appetite will improve
and you’ll get more
enjoyment out of eating!
Be good role model by either not
smoking, or quitting
You’ll Protect Those You Love
2005 2006-2015 (cumulative)
Geographical
regions (WHO
classification)
Total
deaths
(millions)
NCD
deaths
(millions)
NCD
deaths
(millions)
Trend: Death
from infectious
disease
Trend: Death
from NCD
Africa 10.8 2.5 28 +6% +27%
Americas 6.2 4.8 53 -8% +17%
Eastern
Mediterranean
4.3 2.2 25 -10% +25%
Europe 9.8 8.5 88 +7% +4%
South-East Asia 14.7 8.0 89 -16% +21%
Western Pacific 12.4 9.7 105 +1 +20%
Total 58.2 35.7 388 -3% +17%
Noncommunicable Diseases (2006-2015)
Death trends (2006-2015)
WHO projects that over the next 10 years, the largest increase in
deaths from cardiovascular disease, cancer, respiratory disease and
diabetes will occur in developing countries.
(WHO, Chronic Disease Report, 2005)
www.who.int/chp
Noncommunicable diseases in developing countries
are a major public health and socio-economic problem
The major challenge to development
in the 21st century

Noncommunicable Diseases
4 Diseases, 4 Modifiable Shared Risk Factors
Tobacco
Use
Unhealthy
diets
Physical
Inactivity
Harmful
Use of
Alcohol
Cardio-
vascular
Diabetes
Cancer
Chronic
Respiratory
Global Tobacco Control is Underfunded
Globally, tobacco tax
revenues are 500
times higher than
spending on tobacco
control.
In low- and middle-
income countries, tax
revenues are 5,000
times higher.
 Decision makers need to be fully informed with
the up-to-date evidence about the burden and
impacts of chronic diseases.
 Placing Chronic Diseases Higher on the Political
and Health Agenda is a must.
Hypertension: A Growing Problem
Prevalence (%)
United States7
Egypt9
Japan8
Italy7
Sweden7
England7
Spain7
Finland7
Germany7
0 10 20 30 40 50
Taiwan9
Canada7
South Korea9
*Defined as systolic/diastolic blood pressure 140/90, (160/95 for Taiwan) or receiving treatment.
†South Korea is defined as men, aged 30 to 59.
7. Wolf-Maier et al. JAMA. 2003;289:2363-2369; 8. Data on file. Pfizer Inc, New York, NY;
9. WHO Collaborating Centre on Surveillance of Cardiovascular Disease Web site. Available at: www.cvdinfobase.ca. Accessed February 22, 2005.
Egypt Vs World Average
Source: Central Bank of Egypt
Vital Signs Stamp
VITAL SIGNS
Pulse:
Temperature:
Respiratory Rate:
(circle one)
Current Former NeverTobacco Use:
Blood Pressure:
Weight:
Fiore et al. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD: US Department of
Health and Human Services, Public Health Service. June 2000.
282
285

More Related Content

What's hot

Smoking cessation
Smoking cessationSmoking cessation
Smoking cessation
Desirae Acree
 
Smoking cessation
Smoking cessationSmoking cessation
Smoking cessation
Kishore Rajan
 
Smoking and cvd
Smoking and cvdSmoking and cvd
Smoking and cvd
GOPAL GHOSH
 
E cigarettes vaping and vaping induced lung injury EVALI
E cigarettes vaping and vaping induced lung injury EVALIE cigarettes vaping and vaping induced lung injury EVALI
E cigarettes vaping and vaping induced lung injury EVALI
Dr.Aslam calicut
 
Smoking cessation
Smoking cessationSmoking cessation
Smoking cessation
Saad Hossain Tapu
 
Smoking prevention and cessation
Smoking prevention and cessationSmoking prevention and cessation
Smoking prevention and cessationReynel Dan
 
Smokers heart
Smokers heartSmokers heart
Smokers heart
Sanjeev K Agarwal
 
Study the Harmfull Effect of Smoking among the Adult in the Rural Area of Nas...
Study the Harmfull Effect of Smoking among the Adult in the Rural Area of Nas...Study the Harmfull Effect of Smoking among the Adult in the Rural Area of Nas...
Study the Harmfull Effect of Smoking among the Adult in the Rural Area of Nas...
SSR Institute of International Journal of Life Sciences
 
Dr. Ebbert Spit Tobacco Presentation
Dr. Ebbert Spit Tobacco PresentationDr. Ebbert Spit Tobacco Presentation
Dr. Ebbert Spit Tobacco Presentation
Catalyst
 
TOBACCO CESSATION
TOBACCO CESSATION TOBACCO CESSATION
TOBACCO CESSATION
DR YASMIN MOIDIN
 
Presentation on tobacco
Presentation on tobaccoPresentation on tobacco
Presentation on tobaccosaskohc
 
Tobacco awareness ppt - smoking ppt
Tobacco awareness ppt - smoking pptTobacco awareness ppt - smoking ppt
Tobacco awareness ppt - smoking ppt
Pendem Raju
 
Tobacco Harm Reduction Nigeria
Tobacco Harm Reduction NigeriaTobacco Harm Reduction Nigeria
Tobacco Harm Reduction Nigeria
ProfRx
 
Lecture 2: Smoking Cessation
Lecture 2: Smoking CessationLecture 2: Smoking Cessation
Lecture 2: Smoking Cessation
Babette Parthum
 
Smokingcessationpresentation dr-131108232025-phpapp02
Smokingcessationpresentation dr-131108232025-phpapp02Smokingcessationpresentation dr-131108232025-phpapp02
Smokingcessationpresentation dr-131108232025-phpapp02
Georgi Daskalov
 
Biology ammu.pptx 2
Biology ammu.pptx 2Biology ammu.pptx 2
Biology ammu.pptx 2
Rasika Patil
 

What's hot (19)

Smoking cessation
Smoking cessationSmoking cessation
Smoking cessation
 
Smoking cessation
Smoking cessationSmoking cessation
Smoking cessation
 
Smoking and cvd
Smoking and cvdSmoking and cvd
Smoking and cvd
 
E cigarettes vaping and vaping induced lung injury EVALI
E cigarettes vaping and vaping induced lung injury EVALIE cigarettes vaping and vaping induced lung injury EVALI
E cigarettes vaping and vaping induced lung injury EVALI
 
Smoking cessation
Smoking cessationSmoking cessation
Smoking cessation
 
Smoking prevention and cessation
Smoking prevention and cessationSmoking prevention and cessation
Smoking prevention and cessation
 
Smokers heart
Smokers heartSmokers heart
Smokers heart
 
Dr luciano hammes
Dr luciano hammesDr luciano hammes
Dr luciano hammes
 
Study the Harmfull Effect of Smoking among the Adult in the Rural Area of Nas...
Study the Harmfull Effect of Smoking among the Adult in the Rural Area of Nas...Study the Harmfull Effect of Smoking among the Adult in the Rural Area of Nas...
Study the Harmfull Effect of Smoking among the Adult in the Rural Area of Nas...
 
Dr. Ebbert Spit Tobacco Presentation
Dr. Ebbert Spit Tobacco PresentationDr. Ebbert Spit Tobacco Presentation
Dr. Ebbert Spit Tobacco Presentation
 
TOBACCO CESSATION
TOBACCO CESSATION TOBACCO CESSATION
TOBACCO CESSATION
 
Presentation on tobacco
Presentation on tobaccoPresentation on tobacco
Presentation on tobacco
 
Smoking
SmokingSmoking
Smoking
 
Tobacco awareness ppt - smoking ppt
Tobacco awareness ppt - smoking pptTobacco awareness ppt - smoking ppt
Tobacco awareness ppt - smoking ppt
 
Tobacco Harm Reduction Nigeria
Tobacco Harm Reduction NigeriaTobacco Harm Reduction Nigeria
Tobacco Harm Reduction Nigeria
 
Lecture 2: Smoking Cessation
Lecture 2: Smoking CessationLecture 2: Smoking Cessation
Lecture 2: Smoking Cessation
 
Smokingcessationpresentation dr-131108232025-phpapp02
Smokingcessationpresentation dr-131108232025-phpapp02Smokingcessationpresentation dr-131108232025-phpapp02
Smokingcessationpresentation dr-131108232025-phpapp02
 
Copd 2006
Copd 2006Copd 2006
Copd 2006
 
Biology ammu.pptx 2
Biology ammu.pptx 2Biology ammu.pptx 2
Biology ammu.pptx 2
 

Similar to Rewards of smoking cessation 2018

Rewards of Smoking Cessation
Rewards of Smoking CessationRewards of Smoking Cessation
Rewards of Smoking Cessation
Ashraf ElAdawy
 
The health risks of smoking cigarettes
The health risks of smoking cigarettesThe health risks of smoking cigarettes
The health risks of smoking cigarettes
Jane Allen
 
noncommunicablediseasespro1-180101054815.pdf
noncommunicablediseasespro1-180101054815.pdfnoncommunicablediseasespro1-180101054815.pdf
noncommunicablediseasespro1-180101054815.pdf
KristineHP
 
Smoking and Health pdf.docx
Smoking and Health pdf.docxSmoking and Health pdf.docx
Smoking and Health pdf.docx
AnisaKarim2
 
Causal association of Smoking in NCDs
Causal association of Smoking in NCDsCausal association of Smoking in NCDs
Causal association of Smoking in NCDs
Nabiilah Naraino Majie
 
Smoking A Health Hazard
Smoking A Health HazardSmoking A Health Hazard
Smoking A Health Hazard
Avigail Gabaleo Maximo
 
ISPTID 2010 Pres Address Dr Kinnunen; Women & Smoking
ISPTID 2010 Pres Address Dr Kinnunen; Women & Smoking ISPTID 2010 Pres Address Dr Kinnunen; Women & Smoking
ISPTID 2010 Pres Address Dr Kinnunen; Women & Smoking Taru Kinnunen, MA, PhD
 
Quit Smoking
Quit SmokingQuit Smoking
Quit Smoking
arindam_baral
 
Vince mak - respiratory and mental health
Vince mak - respiratory and mental healthVince mak - respiratory and mental health
Vince mak - respiratory and mental health
NHS Improving Quality
 
Tobacco- Impact on Health and Cancer
Tobacco- Impact on Health and CancerTobacco- Impact on Health and Cancer
Tobacco- Impact on Health and Cancer
Debarshi Lahiri
 
Smoke free living
Smoke free livingSmoke free living
Smoke free living
failafraid
 
Dolls case control study
Dolls case control studyDolls case control study
Dolls case control study
Mrinmoy Bharadwaz
 
Physiological effects of smoking on the respiratory system & all other system...
Physiological effects of smoking on the respiratory system & all other system...Physiological effects of smoking on the respiratory system & all other system...
Physiological effects of smoking on the respiratory system & all other system...
martinshaji
 
Smocking
SmockingSmocking
Smocking
Muhammad Khan
 
Smoking Kills Power point presentation
Smoking Kills Power point presentationSmoking Kills Power point presentation
Smoking Kills Power point presentation
HafizMImran1
 
Effects of-smoking-and-need-for-cessation-biochemical-and-pharmacological-fee...
Effects of-smoking-and-need-for-cessation-biochemical-and-pharmacological-fee...Effects of-smoking-and-need-for-cessation-biochemical-and-pharmacological-fee...
Effects of-smoking-and-need-for-cessation-biochemical-and-pharmacological-fee...
Georgi Daskalov
 
smoking statistics
smoking statisticssmoking statistics
smoking statistics
Muhamed Naif
 
lung cancer
lung                                 cancerlung                                 cancer
lung cancer
Mohamed Alashram
 

Similar to Rewards of smoking cessation 2018 (20)

Rewards of Smoking Cessation
Rewards of Smoking CessationRewards of Smoking Cessation
Rewards of Smoking Cessation
 
The health risks of smoking cigarettes
The health risks of smoking cigarettesThe health risks of smoking cigarettes
The health risks of smoking cigarettes
 
College Smoking
College SmokingCollege Smoking
College Smoking
 
noncommunicablediseasespro1-180101054815.pdf
noncommunicablediseasespro1-180101054815.pdfnoncommunicablediseasespro1-180101054815.pdf
noncommunicablediseasespro1-180101054815.pdf
 
Smoking and Health pdf.docx
Smoking and Health pdf.docxSmoking and Health pdf.docx
Smoking and Health pdf.docx
 
Causal association of Smoking in NCDs
Causal association of Smoking in NCDsCausal association of Smoking in NCDs
Causal association of Smoking in NCDs
 
Smoking A Health Hazard
Smoking A Health HazardSmoking A Health Hazard
Smoking A Health Hazard
 
ISPTID 2010 Pres Address Dr Kinnunen; Women & Smoking
ISPTID 2010 Pres Address Dr Kinnunen; Women & Smoking ISPTID 2010 Pres Address Dr Kinnunen; Women & Smoking
ISPTID 2010 Pres Address Dr Kinnunen; Women & Smoking
 
Quit Smoking
Quit SmokingQuit Smoking
Quit Smoking
 
Vince mak - respiratory and mental health
Vince mak - respiratory and mental healthVince mak - respiratory and mental health
Vince mak - respiratory and mental health
 
Tobacco- Impact on Health and Cancer
Tobacco- Impact on Health and CancerTobacco- Impact on Health and Cancer
Tobacco- Impact on Health and Cancer
 
Smoke free living
Smoke free livingSmoke free living
Smoke free living
 
Dolls case control study
Dolls case control studyDolls case control study
Dolls case control study
 
Physiological effects of smoking on the respiratory system & all other system...
Physiological effects of smoking on the respiratory system & all other system...Physiological effects of smoking on the respiratory system & all other system...
Physiological effects of smoking on the respiratory system & all other system...
 
Smocking
SmockingSmocking
Smocking
 
Smoking Kills Power point presentation
Smoking Kills Power point presentationSmoking Kills Power point presentation
Smoking Kills Power point presentation
 
Effects of-smoking-and-need-for-cessation-biochemical-and-pharmacological-fee...
Effects of-smoking-and-need-for-cessation-biochemical-and-pharmacological-fee...Effects of-smoking-and-need-for-cessation-biochemical-and-pharmacological-fee...
Effects of-smoking-and-need-for-cessation-biochemical-and-pharmacological-fee...
 
smoking statistics
smoking statisticssmoking statistics
smoking statistics
 
Smoking
SmokingSmoking
Smoking
 
lung cancer
lung                                 cancerlung                                 cancer
lung cancer
 

More from Ashraf ElAdawy

How to get your taste and smell back after covid-19?
How to get your taste and smell back after covid-19?How to get your taste and smell back after covid-19?
How to get your taste and smell back after covid-19?
Ashraf ElAdawy
 
Quadrivalent influenza vaccine
Quadrivalent influenza vaccineQuadrivalent influenza vaccine
Quadrivalent influenza vaccine
Ashraf ElAdawy
 
Brain fog, insomnia, and stress: Coping after COVID
Brain fog, insomnia, and stress: Coping after COVIDBrain fog, insomnia, and stress: Coping after COVID
Brain fog, insomnia, and stress: Coping after COVID
Ashraf ElAdawy
 
How to manage fatigue after covid-19
How to manage fatigue after covid-19How to manage fatigue after covid-19
How to manage fatigue after covid-19
Ashraf ElAdawy
 
Managing breathlessness with long covid
Managing breathlessness with long covidManaging breathlessness with long covid
Managing breathlessness with long covid
Ashraf ElAdawy
 
Post COVID Syndrome
Post COVID SyndromePost COVID Syndrome
Post COVID Syndrome
Ashraf ElAdawy
 
COVID-19 &Tuberculosis What is The Link?
COVID-19 &Tuberculosis  What is The Link?COVID-19 &Tuberculosis  What is The Link?
COVID-19 &Tuberculosis What is The Link?
Ashraf ElAdawy
 
COVID-19 : A look at possible future Scenarios?
COVID-19 : A look at possible future Scenarios?  COVID-19 : A look at possible future Scenarios?
COVID-19 : A look at possible future Scenarios?
Ashraf ElAdawy
 
Asthma, COPD with COVID-19: What should HCPs need to know?
Asthma, COPD with COVID-19: What should HCPs need to know?Asthma, COPD with COVID-19: What should HCPs need to know?
Asthma, COPD with COVID-19: What should HCPs need to know?
Ashraf ElAdawy
 
Novel coronavirus (COVID-2019) What we need to know?
Novel coronavirus (COVID-2019) What we need to know?Novel coronavirus (COVID-2019) What we need to know?
Novel coronavirus (COVID-2019) What we need to know?
Ashraf ElAdawy
 
فيروس الكورونا المستجد 2019
فيروس الكورونا المستجد 2019فيروس الكورونا المستجد 2019
فيروس الكورونا المستجد 2019
Ashraf ElAdawy
 
Novel corona virus 2019 (2019 - nCov)
Novel corona virus 2019 (2019 - nCov) Novel corona virus 2019 (2019 - nCov)
Novel corona virus 2019 (2019 - nCov)
Ashraf ElAdawy
 
Asthma Inhaler Techniques In Children
 Asthma Inhaler Techniques In Children Asthma Inhaler Techniques In Children
Asthma Inhaler Techniques In Children
Ashraf ElAdawy
 
Asthma Medications in Clinical Practice - Part 2
Asthma Medications in Clinical Practice - Part 2Asthma Medications in Clinical Practice - Part 2
Asthma Medications in Clinical Practice - Part 2
Ashraf ElAdawy
 
Asthma Mangement: Time for a New Approach
Asthma Mangement: Time for a New ApproachAsthma Mangement: Time for a New Approach
Asthma Mangement: Time for a New Approach
Ashraf ElAdawy
 
Updates on pharmacological management of COPD 2020
Updates on pharmacological management of COPD 2020Updates on pharmacological management of COPD 2020
Updates on pharmacological management of COPD 2020
Ashraf ElAdawy
 
Asthma Medications in Clinical Practice - Part 1
Asthma Medications in Clinical Practice - Part 1Asthma Medications in Clinical Practice - Part 1
Asthma Medications in Clinical Practice - Part 1
Ashraf ElAdawy
 
Asthma and inhaler usage tips - part 2
Asthma and inhaler usage tips - part 2Asthma and inhaler usage tips - part 2
Asthma and inhaler usage tips - part 2
Ashraf ElAdawy
 
Pneumococcal vaccine in adults “Clinical Scenarios”
Pneumococcal vaccine in adults “Clinical Scenarios”Pneumococcal vaccine in adults “Clinical Scenarios”
Pneumococcal vaccine in adults “Clinical Scenarios”
Ashraf ElAdawy
 
Pneumococcal vaccine in adults with CKD “Clinical Scenarios”
Pneumococcal vaccine in adults with CKD “Clinical Scenarios”Pneumococcal vaccine in adults with CKD “Clinical Scenarios”
Pneumococcal vaccine in adults with CKD “Clinical Scenarios”
Ashraf ElAdawy
 

More from Ashraf ElAdawy (20)

How to get your taste and smell back after covid-19?
How to get your taste and smell back after covid-19?How to get your taste and smell back after covid-19?
How to get your taste and smell back after covid-19?
 
Quadrivalent influenza vaccine
Quadrivalent influenza vaccineQuadrivalent influenza vaccine
Quadrivalent influenza vaccine
 
Brain fog, insomnia, and stress: Coping after COVID
Brain fog, insomnia, and stress: Coping after COVIDBrain fog, insomnia, and stress: Coping after COVID
Brain fog, insomnia, and stress: Coping after COVID
 
How to manage fatigue after covid-19
How to manage fatigue after covid-19How to manage fatigue after covid-19
How to manage fatigue after covid-19
 
Managing breathlessness with long covid
Managing breathlessness with long covidManaging breathlessness with long covid
Managing breathlessness with long covid
 
Post COVID Syndrome
Post COVID SyndromePost COVID Syndrome
Post COVID Syndrome
 
COVID-19 &Tuberculosis What is The Link?
COVID-19 &Tuberculosis  What is The Link?COVID-19 &Tuberculosis  What is The Link?
COVID-19 &Tuberculosis What is The Link?
 
COVID-19 : A look at possible future Scenarios?
COVID-19 : A look at possible future Scenarios?  COVID-19 : A look at possible future Scenarios?
COVID-19 : A look at possible future Scenarios?
 
Asthma, COPD with COVID-19: What should HCPs need to know?
Asthma, COPD with COVID-19: What should HCPs need to know?Asthma, COPD with COVID-19: What should HCPs need to know?
Asthma, COPD with COVID-19: What should HCPs need to know?
 
Novel coronavirus (COVID-2019) What we need to know?
Novel coronavirus (COVID-2019) What we need to know?Novel coronavirus (COVID-2019) What we need to know?
Novel coronavirus (COVID-2019) What we need to know?
 
فيروس الكورونا المستجد 2019
فيروس الكورونا المستجد 2019فيروس الكورونا المستجد 2019
فيروس الكورونا المستجد 2019
 
Novel corona virus 2019 (2019 - nCov)
Novel corona virus 2019 (2019 - nCov) Novel corona virus 2019 (2019 - nCov)
Novel corona virus 2019 (2019 - nCov)
 
Asthma Inhaler Techniques In Children
 Asthma Inhaler Techniques In Children Asthma Inhaler Techniques In Children
Asthma Inhaler Techniques In Children
 
Asthma Medications in Clinical Practice - Part 2
Asthma Medications in Clinical Practice - Part 2Asthma Medications in Clinical Practice - Part 2
Asthma Medications in Clinical Practice - Part 2
 
Asthma Mangement: Time for a New Approach
Asthma Mangement: Time for a New ApproachAsthma Mangement: Time for a New Approach
Asthma Mangement: Time for a New Approach
 
Updates on pharmacological management of COPD 2020
Updates on pharmacological management of COPD 2020Updates on pharmacological management of COPD 2020
Updates on pharmacological management of COPD 2020
 
Asthma Medications in Clinical Practice - Part 1
Asthma Medications in Clinical Practice - Part 1Asthma Medications in Clinical Practice - Part 1
Asthma Medications in Clinical Practice - Part 1
 
Asthma and inhaler usage tips - part 2
Asthma and inhaler usage tips - part 2Asthma and inhaler usage tips - part 2
Asthma and inhaler usage tips - part 2
 
Pneumococcal vaccine in adults “Clinical Scenarios”
Pneumococcal vaccine in adults “Clinical Scenarios”Pneumococcal vaccine in adults “Clinical Scenarios”
Pneumococcal vaccine in adults “Clinical Scenarios”
 
Pneumococcal vaccine in adults with CKD “Clinical Scenarios”
Pneumococcal vaccine in adults with CKD “Clinical Scenarios”Pneumococcal vaccine in adults with CKD “Clinical Scenarios”
Pneumococcal vaccine in adults with CKD “Clinical Scenarios”
 

Recently uploaded

263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
NEHA GUPTA
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 

Recently uploaded (20)

263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 

Rewards of smoking cessation 2018

  • 1. 1
  • 3. By
  • 4. In the past century smoking was common as a symbol of simple pleasures
  • 5. In the past century smoking was common as a symbol of simple pleasures Pipe would stand for thoughtfulness and calm Cigarette symbolized modernity, strength and youth, but also nervous anxiety Cigar was a sign of authority, wealth and power
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20. Times have changed Smoking is less socially acceptable now than ever...
  • 21. Uncovering the effects of smoking historical perspective
  • 22. In retrospect it can now be seen that medical evidence of the harm done by smoking has been accumulating for many years The evidence was generally ignored until five case-control studies relating smoking to the development of lung cancer were published in 1950. The interpretation that smoking caused various diseases was vigorously debated for some years but came to be generally accepted in respect of lung cancer by the late 1950s and of many other diseases in the subsequent two decades.
  • 23.
  • 25. Tobacco : Deadly in any form
  • 26. 26
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32. WHO World Health Report .Tobacco Atlas .2008. Global Cigarette Consumption
  • 33. 33
  • 34.
  • 35.
  • 36. 36
  • 37. Where is the burden increasing the fastest, 1990 to 2020? India +1400%Middle Eastern Crescent +700% India +1400%Middle Eastern Crescent +700% Latin American and Caribbean +300% India +1400% India +1400%Middle Eastern Crescent +700% Latin American and Caribbean +300% Other Asia and Islands +250% India +1400%Middle Eastern Crescent +700% Latin American and Caribbean +300% Sub- Saharan Africa +200% Other Asia and Islands +250% India +1400%Middle Eastern Crescent +700% Latin American and Caribbean +300% Sub- Saharan Africa +200% Other Asia and Islands +250% China +175% India +1400%Middle Eastern Crescent +700% Latin American and Caribbean +300% Sub- Saharan Africa +200% Other Asia and Islands +250% China +175% Formerly Socialist Economies of Europe +120% India +1400%Middle Eastern Crescent +700% Latin American and Caribbean +300% Sub- Saharan Africa +200% Other Asia and Islands +250% China +175% Formerly Socialist Economies of Europe +120% Established Market Economies +18%
  • 38.
  • 39.
  • 40. The Economics of Tobacco andTobacco Taxation in Egypt 2010 International Union Against Tuberculosis and Lung Disease
  • 41. Tobacco Road Map Top 10 male smoking populations 2008
  • 42.
  • 43.
  • 44. Decrease in smoking prevalence • In 1950, about 80% of UK men smoked United Kingdom, 1950-2002 1950 1960 1970 1980 1990 2000 0 20 40 60 80 % at ages 35-59 70% 50% 28% 26% % smoked % smoked • In 1970, UK male death rates from smoking were the worst in the world • 1970-2000, decrease in male death rates from smoking was the best in the world
  • 45. The Decline in US Smoking Prevalence
  • 46.
  • 47. 47
  • 48. Growing Recognition of Value of Smoking Cessation
  • 49.  Smoking cessation intervention is one of the most cost- effective interventions in medicine  Compared with other preventive interventions, smoking cessation is extremely cost-effective.  Smoking cessation has been called the 'gold standard' of health care cost effectiveness, producing additional years of life at costs that are well below those estimated for a wide range of healthcare interventions.
  • 50.  Tobacco-use screening and intervention for adults  Aspirin chemoprophylaxis for adults  Childhood immunization  Colorectal cancer screening  Hypertension screening  Influenza immunization  Pneumococcal immunization  Problem-drinking screening and brief counseling  Vision screening—adults  Cervical cancer screening  Cholesterol screening Smoking Cessation intervention One of the Top 3 Most Important Areas for Focus • The NCPP highlighted priorities among effective clinical preventive services • Total score for each service is based on 2 measures: clinically preventable burden and cost-effectiveness (both scored from 1 to 5 points) Highest Ranking Total Score: 10 Total Score: 8 Total Score: 7 Despite having a high ranking, tobacco-use screening and intervention still have low utilization rates. NCPP=National Commission on Prevention Priorities. Maciosek MV et al. Am J Prev Med. 2006;31(1):52-61. 50
  • 51. Leading Health Agencies and Organizations Have Recognized the Value and Are Advocating for Change – Centers for Disease Control and Prevention (CDC) – US Preventive Services Task Force (USPSTF) – National Business Group on Health (NBGH) – National Commission on Prevention Priorities (NCPP) – World Health Organization (WHO)
  • 52. 52
  • 53.
  • 54. Tobacco use is a risk factor for six of the eight leading causes of death in the world
  • 56.
  • 57.
  • 58. Finally, here’s a nice example of what stopping smoking can offer. Richard Doll (1912-2005), who stopped smoking cigarettes at age 37, photographed aged 91 at the 2004 BMJ press conference on the 50-year results from his study of British doctorsMichael Crabtree, copyright Troika Photos
  • 59. Study of smoking and death in male British doctors • Recorded all deaths for 50 years (1951-2001) • Main findings (for men born in the 20th century) – Smokers lose, on average, 10 years of healthy life • Asked all UK doctors in 1951, and periodically thereafter, what they themselves smoked – Stopping smoking at any age will add years to a persons life – Those who stop smoking before 35 years of age avoid almost all of the excess risk will have a life expectancy no different from that of a nonsmoker.
  • 60. Age40 A Study of Male Physicians Showed Quitting at Any Age Increases Life Expectancy 35-44 years Patients were studied over the period of 1951-2001. Adapted from Doll R et al. BMJ. 2004;328:1519-1527. Years Nonsmokers Cigarette Smokers Stopped Age %SurvivalFromMean Quitatage35-44 Additional 9-year life expectancy 60 N=34,439 British male physicians.
  • 61. A Study of Male Physicians Showed Quitting at Any Age Increases Life Expectancy Patients were studied over the period of 1951-2001. Adapted from Doll R et al. BMJ. 2004;328:1519-1527. Years %SurvivalFromMean Age50 Quitatage45-54 Additional 6-year life expectancy 45-54 years 61 Nonsmokers Cigarette Smokers Stopped Age N=34,439 British male physicians.
  • 62. A Study of Male Physicians Showed Quitting at Any Age Increases Life Expectancy Patients were studied over the period of 1951-2001. Adapted from Doll R et al. BMJ. 2004;328:1519-1527. Years %SurvivalFromMean Age60 Quitatage55-64 Additional 3-year life expectancy 55-64 years 62 Nonsmokers Cigarette Smokers Stopped Age N=34,439 British male physicians.
  • 63.
  • 64.
  • 65.
  • 66.
  • 67. Tobacco is the single largest preventable cause of cancer in the world today
  • 68.
  • 69.
  • 70.
  • 71.
  • 72.
  • 73.
  • 74. 74
  • 75.
  • 76.
  • 77.
  • 78.
  • 79. Stopping smoking: avoiding lung cancer % dead from lung cancer Continued smoking: 16% dead from lung cancer Stopped age 50: 6% Stopped age 30: 2% Never smoked: <1% 15 10 5 0 45 55 65 75 Age Cumulative risk at UK male 1990 rates BMJ 2000; 321: 323-9
  • 80. 80
  • 81. 81
  • 82. 82
  • 83. 83
  • 84. • People diagnosed with cancer should quit smoking. For those having surgery, chemotherapy, quitting smoking helps improve the body’s ability to heal and respond to therapy . • It also lowers the risk of pneumonia and respiratory failure . • For people who have already developed cancer, quitting smoking reduces the risk of the cancer returning or developing a second cancer .
  • 85.
  • 86.
  • 87. 87
  • 88.
  • 89. 89
  • 90.
  • 91.  One out of every five smoking-related deaths are caused by cardiovascular diseases.  Cigarette smokers are two to four times more likely to develop coronary heart disease than non-smokers.  Cigarette smoking doubles a person's risk of stroke.  Cigarette smokers are more than ten times as likely as non-smokers to develop peripheral vascular disease  Smoking causes abdominal aortic aneurysm The American Heart Association
  • 92.  The risk for CAD among smokers is dose related & smoking as little as one to four cigarettes per day significantly increases risk.  Smoking cessation should be viewed as therapeutic rather than preventive intervention.
  • 93. 93
  • 95.
  • 96. 96
  • 97. 97
  • 98. 98
  • 99.
  • 100.
  • 101.
  • 102.
  • 103.
  • 104.  Smokers also have a higher risk of recurrent ischemia after coronary artery bypass graft surgery and of re- occlusion after an acute myocardial infarction  For those smokers with diagnosed CHD, stopping smoking appears to reduce the risk of recurrent infarction and cardiovascular death by 50% or more.
  • 105.  Smoking cessation is crucial in the management of many contributors to heart attack e.g atherosclerosis.  Smoking cessation significantly lowers the risk of atherosclerosis
  • 106.
  • 107.
  • 108.
  • 109.
  • 110. 110
  • 111.
  • 112. The American Heart Association Increases LDL Decreases HDL Slightly increases triglycerides Smoking and hypercholestorlemia
  • 113.
  • 114. 114
  • 115. 115
  • 116. 116
  • 117. The American Heart Association Smoking increases the cardiovascular risk, at any level of blood pressure, for coronary heart disease, stroke Drug treatment of hypertension is less effective in smokers Smoking should be avoided in any hypertensive patient Smoking and hypertension
  • 118. Diabetes and High Blood Pressure are Like Twins
  • 119. 119
  • 120. 120
  • 121.
  • 122. The American Heart Association Smoking has a multiplicative interaction with the major risk factors for coronary artery disease, to increase disease risk. For example, if the presence of smoking alone doubles the level of risk for CAD, the presence of another major risk factor in conjunction with smoking results in approximately a 4-fold increase in risk . The presence of 2 other risk factors together with smoking results in approximately an 8-fold increase in risk. Multiplicative Risk Factor CAD
  • 123. 123
  • 124.
  • 125. 125
  • 126. 126
  • 127. 127
  • 128.
  • 129.
  • 130. 130
  • 131. 131
  • 132. 132
  • 133. 133
  • 134. 134
  • 135. Relationship Between CKD and CVD CKD = chronic kidney disease; CVD = cardiovascular disease; CV = cardiovascular. 1. Menon V et al. Am J Kidney Dis. 2005;45:223–232. CVD CKD Traditional CV risk factors Non-traditional CV risk factors CKD is a risk factor for CVD, and CVD may be a risk factor for the progression of CKD
  • 136. Diabetes or hypertension are the two leading causes of chronic kidney disease. Smokers with diabetes or hypertension face an accelerated rate of kidney damage compared to non-smokers with chronic kidney disease, resulting in a much quicker progress towards ESRD .
  • 137. 137
  • 138. 138 Diabetes Amplifies the CKD and CVD Paradigm
  • 139. 139
  • 140.
  • 141.
  • 142.
  • 143.
  • 144.
  • 145. Smoking Is the Single Most Important Risk Factor for COPD Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2008. Available from: http://www.goldcopd.org.
  • 146. 146
  • 147. 147
  • 148. 1990 2020 Ischaemic heart disease Cerebrovascular disease Lower resp infection Diarrhoeal disease Perinatal disorders COPD Tuberculosis Measles Road Traffic Accidents Lung Cancer Stomach Cancer HIV Suicide 6th 3rd Future Mortality Worldwide Source: Murray & Lopez. Lancet 1997
  • 149. Am. J. Respir. Crit. Care Med. 2002; 166: 675-679 Years FEV1(L) 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 0 1 2 3 4 5 6 7 8 9 10 11 Continuous smokers Disease Progression in COPD Lung Function
  • 150. potential effect of stopping smoking early or late in the course of COPD. Fletcher CM, Peto R. BMJ. 1977;1:1645-1648. Reproduced with permissions from BMJ Publishing Group. Smoked regularly and susceptible to effects of smoke Never smoked or not susceptible to smoke Stopped smoking at 45 (mild COPD) Stopped smoking at 65 (severe COPD) Disability Death FEV1 (%ofvalueatage25) 25 50 75 100 0 Age (years) 25 50 75
  • 151. Smoking and pulmonary function Anthonisen et al. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002.
  • 152. • Smoking Cessation is Single most effective and cost effective intervention to reduce the risk of developing COPD and stop its progression Am J Respir Crit Care Med 2001 CRJ . 10;(Suppl A). 2003
  • 153. Corticosteroid resistance Laboratory Investigation advance online publication 24 July 2006; doi:10.1038/labinvest.3700456
  • 154. 154
  • 155. Smoking doesn't cause asthma, but in people having asthma smoking makes their asthma worse. 155
  • 156. Cigarette smoking in asthma is a risk factor for poor asthma control Emergency department visits as a result of exacerbations of asthma occur more frequently amongst heavy cigarette smokers with asthma Every effort should be made to encourage individuals with asthma who smoke to quit. ERS 2004
  • 157. Cigarette smoking increases the clearance of theophylline by 60–100% in smokers compared with nonsmokers by induction of several metabolising enzymes Cytochrome P450-1A2 Smoking cessation for 1 week reduces the elimination of theophylline by 35%. ERS 2004
  • 158. 158
  • 159. 159
  • 160. 160
  • 161. 161
  • 162. Smoking and TB Form a Deadly Combination
  • 163.  Cigarette smokers may be up to three times more likely to develop latent TB infection than non-smokers  For a person with latent TB infection, cigarette smoking increases their risk of developing active TB disease by two to three times, compared to non-smokers  Smoking influences the clinical progress of TB lesions. Smokers tend to have more cavitary disease, and were more likely to be smear-positive compared to non- smokers
  • 164.  Smoking reduces the effectiveness of TB treatment which can lead to longer periods of infection  Smoking is associated with recurrent tuberculosis disease and increase the risk of relapse  Up to one in every five deaths from tuberculosis could be avoided if the patients were not smokers
  • 165.
  • 166.
  • 167. 167
  • 168.
  • 170.
  • 171. 171
  • 172. 172
  • 173.
  • 174. 174
  • 175.
  • 176. 176
  • 177. Patients submitted to liver transplantation are particularly susceptible to increased postoperative pulmonary complications esp. pneumonia Transplanted patients who smoke have an increased risk for vascular complications including hepatic artery thrombosis
  • 178. Herrero JI. Liver Transpl. 2011 Smoking cessation at least 2 years before liver transplantation can significantly reduce the risk for vascular complications. Smoking cessation should be an essential requirement for liver transplantation candidates to decrease the morbidity arising from vascular complications after liver transplantation.
  • 179. Recurrence of viral hepatitis may be more frequent among liver transplant recipients who are active or former smokers "Encouraging preoperative smoking cessation may be beneficial in improving patient outcomes following transplantation."
  • 180. Other investigators recently reported that smoking was a risk factor in the increased frequency of malignancies after liver transplantation. Smoking cessation after liver transplantation reduced incidence of transplant-related carcinoma
  • 181.
  • 182.
  • 183.
  • 184.
  • 185.
  • 186. 186
  • 187. 187
  • 188.
  • 189. Significant association between smoking and male sexual impotence with the association increasing with the number of cigarettes smoked per day There is no “safe” level of smoking , even light smoking is associated with reduced male fertility AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE 2003 ASH Factsheet: Smoking and reproduction 2008
  • 190.
  • 191. Research has shown that men who smoke are 60% more likely to experience erection problems such as impotence, which is why smoking is considered to one of the prime lifestyle causes of impotence. Not only is smoking a singular cause of impotence, but it can also amplify the effects of some of the other causes of impotence such as diabetes, high blood pressure
  • 192. 193
  • 193. Women who smoke have increased risks for conception delay and for both primary and secondary infertility Smoking cessation by women during their reproductive years reduces the risk for infertility. Smoking causes women to reach menopause one to two years early, but former smokers have an age at natural menopause similar to those who have never smoked AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE 2003 ASH Factsheet: Smoking and reproduction 2008
  • 194. Smoking is strongly associated with an increased risk of spontaneous miscarriage and possibly ectopic pregnancy. Women who smoke during pregnancy are about twice as likely to experience premature rupture of membranes, placental abruption, and placenta previa during pregnancy Pregnant women who smoke cigarettes run an increased risk of having stillborn or premature infants or infants with low birth weight. AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE 2003 ASH Factsheet: Smoking and reproduction 2008
  • 195. Women who stop smoking before pregnancy or during the first 3 to 4 months of pregnancy reduce their risk of having a low birthweight baby to that of women who never smoked Reducing the number of cigarettes smoked, rather than quitting completely, does not appear to benefit birthweight of the foetus.
  • 196. Smoking cigarettes may contribute to inadequate breast milk production In breastfeeding mothers who smoke, milk output is reduced by more than 250 ml per day compared with non- smoking mothers. Nicotine is rapidly transported from the smoking mother’s blood to her breast milk. The infant may be less willing to feed since the breast milk tastes bad. ASH Factsheet: Smoking and reproduction February 2011
  • 197. Smoking should be discouraged for both male and female partners in couples with a history of infertility or recurrent miscarriage. Smoking cessation may improve natural fertility and success rates with infertility treatment. Smoking cessation for at least two months before attempting in vitro fertilization (IVF) significantly improved chances for conception.
  • 198.
  • 199.
  • 200. 201
  • 201.
  • 202.
  • 203.
  • 204.
  • 205.
  • 206. 207
  • 207. 208
  • 208. 209
  • 209. 210
  • 210. 211
  • 211. Smoking has an inhibiting effect on estrogen ,the most important hormone in preventing the loss of bone tissue. Smoking is one of the risk factors for osteoporosis which is a major cause of hip fracture. Postmenopausal women who smoke have lower bone density and an increased risk for hip fracture than women who never smoked. Stopping smoking prevents further excess bone loss.
  • 212. 213
  • 213. 214
  • 214.
  • 215. 216
  • 216.
  • 217. 218
  • 218. 219
  • 219. 220
  • 220. 221
  • 221. 222
  • 222. 223
  • 223. 224
  • 224.
  • 225.
  • 226.
  • 227.
  • 228.
  • 229.
  • 230.
  • 231. Smoking can prematurely age the skin , Smokers’ skin can be prematurely aged by between 10 and 20 years The risk of moderate or severe facial wrinkling is 3 times as high for women who smoke than those who have never smoked and twice as high for male smokers “Tobacco kills beauty and much more.”
  • 232. 234
  • 233.
  • 234. Teenagers care about the immediate benefits to their appearance, well being and financial status rather more than future health gains
  • 235.
  • 236.
  • 237.
  • 238.
  • 239.
  • 240.
  • 241. 243
  • 242. 244
  • 243. 245
  • 244.
  • 245.
  • 246. 248
  • 247. 249
  • 248.
  • 249. 251
  • 250.
  • 251. 253
  • 252. You’ll Save Money Smoking is expensive - multiply how much money you spend on tobacco every day by 365 (days per year).
  • 253. Your Self Esteem Will Improve  You will feel more in control of your life.  Your self esteem will improve by knowing you are doing something positive to help yourself!
  • 254. You’ll Look Better  Your clothes and breath will no longer smell like smoke.  Your teeth will be whiter.  You’ll lose the yellow nicotine stains on your fingers
  • 255. Food Will Taste Better  Your sense of smell and taste will return!  Your appetite will improve and you’ll get more enjoyment out of eating!
  • 256. Be good role model by either not smoking, or quitting
  • 258.
  • 259.
  • 260.
  • 261. 2005 2006-2015 (cumulative) Geographical regions (WHO classification) Total deaths (millions) NCD deaths (millions) NCD deaths (millions) Trend: Death from infectious disease Trend: Death from NCD Africa 10.8 2.5 28 +6% +27% Americas 6.2 4.8 53 -8% +17% Eastern Mediterranean 4.3 2.2 25 -10% +25% Europe 9.8 8.5 88 +7% +4% South-East Asia 14.7 8.0 89 -16% +21% Western Pacific 12.4 9.7 105 +1 +20% Total 58.2 35.7 388 -3% +17% Noncommunicable Diseases (2006-2015) Death trends (2006-2015) WHO projects that over the next 10 years, the largest increase in deaths from cardiovascular disease, cancer, respiratory disease and diabetes will occur in developing countries. (WHO, Chronic Disease Report, 2005)
  • 263. Noncommunicable diseases in developing countries are a major public health and socio-economic problem The major challenge to development in the 21st century 
  • 264. Noncommunicable Diseases 4 Diseases, 4 Modifiable Shared Risk Factors Tobacco Use Unhealthy diets Physical Inactivity Harmful Use of Alcohol Cardio- vascular Diabetes Cancer Chronic Respiratory
  • 265.
  • 266. Global Tobacco Control is Underfunded Globally, tobacco tax revenues are 500 times higher than spending on tobacco control. In low- and middle- income countries, tax revenues are 5,000 times higher.
  • 267.
  • 268.  Decision makers need to be fully informed with the up-to-date evidence about the burden and impacts of chronic diseases.  Placing Chronic Diseases Higher on the Political and Health Agenda is a must.
  • 269.
  • 270.
  • 271.
  • 272. Hypertension: A Growing Problem Prevalence (%) United States7 Egypt9 Japan8 Italy7 Sweden7 England7 Spain7 Finland7 Germany7 0 10 20 30 40 50 Taiwan9 Canada7 South Korea9 *Defined as systolic/diastolic blood pressure 140/90, (160/95 for Taiwan) or receiving treatment. †South Korea is defined as men, aged 30 to 59. 7. Wolf-Maier et al. JAMA. 2003;289:2363-2369; 8. Data on file. Pfizer Inc, New York, NY; 9. WHO Collaborating Centre on Surveillance of Cardiovascular Disease Web site. Available at: www.cvdinfobase.ca. Accessed February 22, 2005.
  • 273.
  • 274.
  • 275. Egypt Vs World Average Source: Central Bank of Egypt
  • 276.
  • 277.
  • 278.
  • 279. Vital Signs Stamp VITAL SIGNS Pulse: Temperature: Respiratory Rate: (circle one) Current Former NeverTobacco Use: Blood Pressure: Weight: Fiore et al. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service. June 2000.
  • 280. 282
  • 281.
  • 282.
  • 283. 285